Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2016001644) DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2016/001644 International Application No.: PCT/GB2015/051899
Publication Date: 07.01.2016 International Filing Date: 29.06.2015
IPC:
G01N 33/68 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
Applicants:
CAMBRIDGE ENTERPRISE LIMITED [GB/GB]; The Old Schools Trinity Lane Cambridge Cambridgeshire CB2 1TN, GB
Inventors:
KLENERMAN, David; GB
LEE, Steven; GB
HORROCKS, Mathew; GB
Agent:
KEIRSTEAD, Tanis; GB
Priority Data:
1411616.430.06.2014GB
Title (EN) DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISORDERS
(FR) DIAGNOSTIC ET TRAITEMENT DE TROUBLES NEURODÉGÉNÉRATIFS
Abstract:
(EN) The invention relates to the diagnosis and treatment of neurodegenerative disorders, such as Parkinson' and Alzheimer's disease. In particular, the invention relates to methods for assessing whether an individual has a neurodegenerative disorders before clinical symptoms appear. The invention also relates to methods for delaying or preventing the onset of clinical symptoms associated with neurodegenerative disorders, as well as to methods for identifying agents useful in the treatment or prevention of neurodegenerative disorders.
(FR) L'invention concerne le diagnostic et le traitement de troubles neurodégénératifs, tels que la maladie de Parkinson et la maladie d'Alzheimer. En particulier, l'invention concerne des procédés pour évaluer si un individu présente ou non un trouble neurodégénératif avant l'apparition de symptômes cliniques. L'invention concerne également des procédés pour retarder ou prévenir l'apparition de symptômes cliniques associés à des troubles neurodégénératifs, ainsi que des procédés pour identifier des agents utiles dans le traitement ou la prévention de troubles neurodégénératifs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)